BRADY KELLY (See Remarks) sold 0.7% of their position (59.00 shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $444.27 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/19/2026ACC: 0001193125-26-230732
Officer· See Remarks
Since Mar 2026
-59.00
Net shares
Net seller
$444.27
Total sold
1
Open market trades
0B · 1S
4
Total transactions
180.00 acquired · 239.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+180.00
Price / share
—
Trade value
—
% of position
2.1%
5/15/2026
8.44K→8.62K
Common Stock
Direct
Shares
−59.00
Price / share
$7.53
Trade value
$444.27
% of position
0.7%
5/18/2026
8.62K→8.56K
Total
Net shares
+121.00
Net value
-$444.27
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | M · Option Exercise | +180.00 | — | — | 2.1% | 8.44K | 8.62K |
| Common Stock Direct | 5/18/2026 | S · Sale | −59.00 | $7.53 | $444.27 | 0.7% | 8.62K | 8.56K |
| Total | +121.00 | -$444.27 | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
89.00 shares
Shares
−89.00
Strike price
Held after
269.00
Exercisable
—
5/15/2026
Restricted Stock Units
Direct
Converts to
Common Stock
91.00 shares
Shares
−91.00
Strike price
Held after
639.00
Exercisable
—
5/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock89.00 shares | 5/15/2026 | M · Option Exercise | −89.00 | — | 269.00 | |
| Restricted Stock Units Direct | Common Stock91.00 shares | 5/15/2026 | M · Option Exercise | −91.00 | — | 639.00 |